Company
Headquarters: Shanghai, China
Employees: 1,308
CEO: Dr. Xiucai Liu
CN¥25.49 Billion
CNY as of Jan. 1, 2025
US$3.49 Billion
| Company | Market Cap (USD) |
|---|---|
| Air Liquide SA | $97.26 B |
| Air Products and Chemicals, Inc. | $72.05 B |
| Shin-Etsu Chemical Co Ltd | $63.76 B |
| Saudi Basic Industries Corp | $54.94 B |
| BASF SE | $42.22 B |
| Company | Market Cap (USD) |
|---|---|
| Linde | $209.90 B |
| BHP | $151.21 B |
| Rio Tinto | $102.04 B |
| Air Liquide SA | $97.26 B |
| The Sherwin-Williams Company | $90.95 B |
Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥2.76 B |
| EBITDA | CN¥530.9 M |
| Gross Profit TTM | CN¥846.7 M |
| Profit Margin | 14.39% |
| Operating Margin | 20.38% |
| Quarterly Revenue Growth | 44.10% |
Cathay Biotech, Inc. has the following listings and related stock indices.
Stock: SSE: 688065 wb_incandescent